ImmuCell Corp. (Nasdaq: ICCC), a Portland biotech company that makes preventive health products for beef and dairy cattle, on Thursday reported that its sales for the year’s third quarter increased 25% over the same period in 2019.

Sales rose $752,000 to $3.7 million during the three-month period that ended Sept. 30, 2020.

For the first nine months of the year, sales totaled $11.6 million, an increase of 15% or $1.5 million, over that period in 2019. Read more